Kent Rogers

Kent is a healthcare executive with 30 years of extensive brand and generic pharmaceutical, specialty/infusion pharmacy, wholesale drug distribution, payor, and supply-chain leadership experience. He served as the CEO of EveryONE Medicines, a Venture Partner with ARCH Venture Partners, as Chief Commercial Officer for EQRx, Chief Industry Relations Officer for OptumRx (United Health Group’s PBM), Principal with Blue Fin Group (an IntegriChain company), the Global Vice President of Market Access with Acorda Therapeutics and various leadership roles with Schering Plough and Merck. He has served in multiple advisory roles for pharmaceutical firms, payer organizations and the National Business Group on Health. 

Kent earned his MBA in International Business at Emory University’s Goizueta Business School and received his BS in Business Management & Organizational Change at Indiana University's Kelley School of Business. 

Kent joins CarelonRx as the President of CarelonRx PBM. He brings a unique skill set and experience having held executive leadership positions with multiple top-tier pharmaceutical companies and emerging biotech firms, in supply-chain consulting and in venture capital. In addition, Kent served as a senior executive with OptumRx. Throughout his career, he has taken active roles in bringing disruptive solutions to the healthcare supply chain, creating a pathway for access to new medicines that address critical disease states. In his role leading the CarelonRx PBM, he has full P&L responsibility over the trade, network, product and growth strategies.